Larissa Anastasio Da Costa Carvalho

5PUBLICATIONS
50CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical infection agents (incl. prions)Nanoscale characterisation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 04, 2025
RAS(ON) Multiselective Inhibition Drives Antitumor Immunity in Preclinical Models of NRAS-Mutant Melanoma.

Larissa Anastacio Da Costa Carvalho, Nataliya Tovbis Shifrin, Manali S Phadke

|Nov 29, 2023
HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasis.

Michael F Emmons, Richard L Bennett, Alberto Riva

|Jan 18, 2022
Upregulation of the novel lncRNA U731166 is associated with migration, invasion and vemurafenib resistance in melanoma.

Ádamo Davi Diógenes Siena, Isabela Ichihara de Barros, Camila Baldin Storti

|Jul 15, 2021
Loss of mTORC2 Activity in Neutrophils Impairs Fusion of Granules and Affects Cellular Metabolism Favoring Increased Bacterial Burden in Sepsis.

Cristiane Naffah de Souza Breda, Leandro Carvalho Dantas Breda, Larissa Anastácio da Costa Carvalho

|Jun 04, 2021
Nanostructured lipid carriers enhances the safety profile of tretinoin: in vitro and healthy human volunteers' studies.

Flávia A Lima, Raquel Vr Vilela, Rodrigo L Oréfice

Pageof 1